|
MCM3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.8943000000018E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67792999999916E-05 |
| Normal-vs-Stage2 |
4.882200E-02 |
| Normal-vs-Stage3 |
1.659670E-02 |
| Normal-vs-Stage4 |
1.277240E-01 |
| Stage1-vs-Stage2 |
3.024000E-01 |
| Stage1-vs-Stage3 |
1.219440E-01 |
| Stage1-vs-Stage4 |
8.683700E-02 |
| Stage2-vs-Stage3 |
9.204800E-01 |
| Stage2-vs-Stage4 |
6.120200E-01 |
| Stage3-vs-Stage4 |
6.263200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.208610E-04 |
| Normal-vs-AfricanAmerican |
3.865800E-02 |
| Normal-vs-Asian |
7.52300000000927E-05 |
| Caucasian-vs-AfricanAmerican |
7.269800E-01 |
| Caucasian-vs-Asian |
6.408100E-02 |
| AfricanAmerican-vs-Asian |
4.021800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.878500E-03 |
| Normal-vs-Female |
7.88350000000548E-05 |
| Male-vs-Female |
5.123200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.91229999999288E-06 |
| Normal-vs-Age(41-60Yrs) |
1.598030E-03 |
| Normal-vs-Age(61-80Yrs) |
6.085900E-02 |
| Normal-vs-Age(81-100Yrs) |
6.075000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.504300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.996150E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.186000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.316600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.611200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.175000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.640000E-01 |
| Classical-VS-Follicular |
1.998510E-04 |
| Classical-VS-Other |
3.273000E-01 |
| Classical-VS-Normal |
6.0321999995061E-07 |
| Tall-VS-Follicular |
3.606400E-02 |
| Tall-VS-Other |
5.073000E-01 |
| Tall-VS-Normal |
5.860200E-03 |
| Follicular-VS-Other |
7.025200E-01 |
| Follicular-VS-Normal |
6.348400E-01 |
| Other-VS-Normal |
6.035800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.565800E-04 |
| Normal-vs-N1 |
1.266360E-01 |
| N0-vs-N1 |
4.279800E-01 |
|
|
